Cancer patients report more memory lapses, study finds

NCT ID NCT03975959

Completed Knowledge-focused Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at memory complaints in 426 people, including those with brain tumors, breast cancer, and healthy volunteers. Participants filled out questionnaires about their memory, mood, and fatigue. The goal was to understand how cancer and its treatments might affect everyday memory, especially the ability to remember future tasks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify new targets for psychological support to improve memory complaints in cancer patients.
What could go wrong: This is an observational study, not a treatment trial. It only measures subjective complaints, so it may not lead to direct improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm glioblastoma glioma low grade glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER GLIOBLASTOMA GLIOMA HEALTHY

Contacts and locations

Locations

CHU D'amiens

Amiens, Nord, 80080, France
CHU Lyon

Saint-Genis-Laval, 69230, France
Hopital saint Louis

Paris, 75010, France
Hôpital d'Instruction des Armées

Clamart, 92190, France
Icm Val D'Aurelle

Montpellier, Herault, 34298, France
UFR de Psychologie Université de Lille

Villeneuve-d'Ascq, NORD, 59653, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.